JP2023525822A5 - - Google Patents
Info
- Publication number
- JP2023525822A5 JP2023525822A5 JP2022568925A JP2022568925A JP2023525822A5 JP 2023525822 A5 JP2023525822 A5 JP 2023525822A5 JP 2022568925 A JP2022568925 A JP 2022568925A JP 2022568925 A JP2022568925 A JP 2022568925A JP 2023525822 A5 JP2023525822 A5 JP 2023525822A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- amino acid
- acid sequence
- tmmp
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063023840P | 2020-05-12 | 2020-05-12 | |
| US63/023,840 | 2020-05-12 | ||
| US202063041506P | 2020-06-19 | 2020-06-19 | |
| US63/041,506 | 2020-06-19 | ||
| PCT/KR2021/005913 WO2021230638A1 (en) | 2020-05-12 | 2021-05-11 | Multimeric t-cell modulatory polypeptides and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023525822A JP2023525822A (ja) | 2023-06-19 |
| JP2023525822A5 true JP2023525822A5 (https=) | 2024-05-22 |
Family
ID=78524648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568925A Ceased JP2023525822A (ja) | 2020-05-12 | 2021-05-11 | 多量体ｔ細胞調節性ポリペプチド及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230241192A1 (https=) |
| EP (1) | EP4149953A4 (https=) |
| JP (1) | JP2023525822A (https=) |
| KR (1) | KR20230009391A (https=) |
| CN (1) | CN115605494A (https=) |
| AU (1) | AU2021271778B2 (https=) |
| CA (1) | CA3178427A1 (https=) |
| TW (1) | TW202208396A (https=) |
| WO (1) | WO2021230638A1 (https=) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003106682A1 (ja) * | 2002-06-12 | 2003-12-24 | 中外製薬株式会社 | Ｈｌａ−ａ２４拘束性癌抗原ペプチド |
| JP6163486B2 (ja) * | 2012-07-02 | 2017-07-12 | 大日本住友製薬株式会社 | 癌抗原ペプチド経皮剤 |
| WO2015195531A2 (en) * | 2014-06-18 | 2015-12-23 | Albert Einstein College Of Medicine, Inc. | Syntac polypeptides and uses thereof |
| ES2805094T3 (es) * | 2014-12-11 | 2021-02-10 | Int Inst Cancer Immunology Inc | Inmunoterapia WT1 para enfermedad angiogénica intraocular |
| CN107921106B (zh) * | 2015-05-20 | 2023-09-08 | 住友制药株式会社 | Wt1抗原肽和免疫调节剂的组合用途 |
| EP3678691A4 (en) * | 2017-09-07 | 2021-06-09 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| JP2020534352A (ja) * | 2017-09-07 | 2020-11-26 | キュー バイオファーマ，インコーポレーテッド | コンジュゲーション部位を有するｔ細胞調節多量体ポリペプチド及びその使用方法 |
| CN111886241A (zh) * | 2018-01-09 | 2020-11-03 | 库尔生物制药有限公司 | 多聚体t细胞调节多肽及其使用方法 |
| CA3115240A1 (en) * | 2018-10-05 | 2020-04-09 | International Institute Of Cancer Immunology, Inc. | Composition for preventing or treating benign tumor |
| TWI856047B (zh) * | 2018-12-19 | 2024-09-21 | 美商信號生物製藥公司 | 多聚體ｔ細胞調節多肽及其使用方法 |
-
2021
- 2021-05-11 WO PCT/KR2021/005913 patent/WO2021230638A1/en not_active Ceased
- 2021-05-11 EP EP21803100.3A patent/EP4149953A4/en active Pending
- 2021-05-11 AU AU2021271778A patent/AU2021271778B2/en active Active
- 2021-05-11 TW TW110116996A patent/TW202208396A/zh unknown
- 2021-05-11 CA CA3178427A patent/CA3178427A1/en active Pending
- 2021-05-11 KR KR1020227039638A patent/KR20230009391A/ko active Pending
- 2021-05-11 CN CN202180033837.4A patent/CN115605494A/zh active Pending
- 2021-05-11 JP JP2022568925A patent/JP2023525822A/ja not_active Ceased
-
2022
- 2022-11-11 US US18/054,691 patent/US20230241192A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272085B (en) | Multimeric t-cell modulatory polypeptides and methods of use thereof | |
| JP2022536581A5 (https=) | ||
| JP2022515330A5 (https=) | ||
| JP2022548472A5 (https=) | ||
| Garboczi et al. | Assembly, specific binding, and crystallization of a human TCR-αβ with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2 | |
| JP2023526723A5 (https=) | ||
| Kelly et al. | A new human HLA class II-related locus, DM | |
| Born et al. | Peptide sequences of T-cell receptor δ and γ chains are identical to predicted X and γ proteins | |
| JP2021500855A5 (https=) | ||
| Samelson et al. | Identification of the components of the murine T cell antigen receptor complex | |
| Acuto et al. | Purification and NH2-terminal amino acid sequencing of the beta subunit of a human T-cell antigen receptor. | |
| IL308851B2 (en) | T-cell modulatory multimeric polypeptides and methods of use thereof | |
| Robb et al. | Sequence of the COOH-terminal hydrophilic region of histocompatibility antigens HLA-A2 and HLA-B7 | |
| Springer et al. | Sequence homology of the LFA-1 and Mac-1 leukocyte adhesion glycoproteins and unexpected relation to leukocyte interferon | |
| JP2019512222A5 (https=) | ||
| JP2025138715A5 (https=) | ||
| JP2020511949A5 (https=) | ||
| JP2022515331A5 (https=) | ||
| JP2022534846A5 (https=) | ||
| JP2019522466A5 (https=) | ||
| JP2017527272A5 (https=) | ||
| JP2022522405A5 (https=) | ||
| CA2318482A1 (en) | Il-18 receptors | |
| JP2018519803A5 (https=) | ||
| Brown et al. | Expression of immunoglobulin and scavenger receptor superfamily domains as chimeric proteins with domains 3 and 4 of CD4 for ligand analysis |